77278-93-4 Usage
Description
1-(TERT-BUTOXYCARBONYL)-4-((2-PYRIDYL)METHYL)PIPERAZINE is a complex chemical compound featuring a piperazine ring with a tert-butoxycarbonyl group and a 2-pyridylmethyl group. It is utilized in the synthesis of pharmaceuticals and organic compounds, with the tert-butoxycarbonyl group serving as a protective agent in organic synthesis and the 2-pyridylmethyl group being a common feature in various pharmaceutical compounds. This unique structure positions it as a valuable building block in medicinal chemistry and drug development.
Uses
Used in Pharmaceutical Synthesis:
1-(TERT-BUTOXYCARBONYL)-4-((2-PYRIDYL)METHYL)PIPERAZINE is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the formation of complex molecular structures that can have therapeutic effects.
Used in Organic Compounds Synthesis:
In the field of organic chemistry, 1-(TERT-BUTOXYCARBONYL)-4-((2-PYRIDYL)METHYL)PIPERAZINE is used as a building block for creating new organic compounds, taking advantage of its reactive functional groups to form a variety of chemical entities.
Used in Medicinal Chemistry:
1-(TERT-BUTOXYCARBONYL)-4-((2-PYRIDYL)METHYL)PIPERAZINE is utilized as a key component in medicinal chemistry, where its structure can be optimized to develop new drugs with specific therapeutic targets.
Used in Drug Development:
In drug development, 1-(TERT-BUTOXYCARBONYL)-4-((2-PYRIDYL)METHYL)PIPERAZINE is used as a starting material to create potential drug candidates, leveraging its unique structural features to design molecules with desired pharmacological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 77278-93-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,2,7 and 8 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 77278-93:
(7*7)+(6*7)+(5*2)+(4*7)+(3*8)+(2*9)+(1*3)=174
174 % 10 = 4
So 77278-93-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H23N3O2/c1-15(2,3)20-14(19)18-10-8-17(9-11-18)12-13-6-4-5-7-16-13/h4-7H,8-12H2,1-3H3
77278-93-4Relevant articles and documents
PIPERAZINE DERIVATIVES FOR TREATING DISORDERS
-
Page/Page column 33; 34; 35, (2015/11/09)
Anti-angiogenic treatments, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of reducing the risk of pre-eclampsia and compounds for use in such methods are described.
Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK3 receptor
Hoveyda, Hamid R.,Roy, Marie-Odile,Blanc, Sebastien,No?l, Sophie,Salvino, Joseph M.,Ator, Mark A.,Fraser, Graeme
scheme or table, p. 1991 - 1996 (2011/04/24)
A series of 3-aryl-5-acylpiperazinyl-pyrazoles (e.g., 3a-b) initially identified through a high-throughput screening campaign using the aequorin Ca2+ bioluminescence assay as novel, potent small molecule antagonists of the G protein-coupled hum
(2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists
-
, (2008/06/13)
The present invention relates to new (2-alkyl-3-pyridyl) methylpiperazine derivatives of general formula I: wherein R1, R2 and Z are as defined in Claim 1. The invention also relates to processes for their preparation and to pharmaceutical compositions containing them. These compounds are potent, orally active PAF antagonists and, consequently, they are useful in the treatment of the diseases in which this substance is involved.
